Malignant Soft Tissue Neoplasm
NCI Definition: A malignant neoplasm arising exclusively from the soft tissues. 
Malignant soft tissue neoplasms most frequently harbor alterations in KIT, TP53, CDKN2A, CDKN2B, and RB1 .
KIT Mutation, KIT Exon 11 Mutation, KIT Deletion, KIT Exon 11 Deletion, and TP53 Mutation are the most common alterations in malignant soft tissue neoplasm .
There is 1 clinical trial for malignant soft tissue neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains malignant soft tissue neoplasm as an inclusion criterion, 1 is phase 1 (1 open).
T3011 is the most common intervention in malignant soft tissue neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.